- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 471/08 - Bridged systems
Patent holdings for IPC class C07D 471/08
Total number of patents in this class: 1777
10-year publication summary
|
151
|
134
|
124
|
146
|
151
|
163
|
151
|
164
|
159
|
31
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
64 |
| Merck Sharp & Dohme LLC | 3689 |
52 |
| Wockhardt Limited | 239 |
49 |
| Purdue Pharma L.P. | 519 |
39 |
| Neurosearch A/S | 222 |
37 |
| Boehringer Ingelheim International GmbH | 4629 |
36 |
| Meiji Seika Pharma Co., Ltd. | 244 |
34 |
| Novartis AG | 11238 |
31 |
| Gilead Sciences, Inc. | 1879 |
28 |
| Skyhawk Therapeutics, Inc. | 93 |
26 |
| Nippon Chemiphar Co., Ltd. | 233 |
23 |
| Achillion Pharmaceuticals, Inc. | 176 |
22 |
| Hoffmann-La Roche Inc. | 3060 |
18 |
| Janssen Pharmaceutica N.V. | 3839 |
18 |
| Takeda Pharmaceutical Company Limited | 2961 |
18 |
| Vertex Pharmaceuticals Incorporated | 1581 |
18 |
| Rigel Pharmaceuticals, Inc. | 613 |
17 |
| Merck Patent GmbH | 5909 |
16 |
| F. Hoffmann-La Roche AG | 7958 |
15 |
| Amgen Inc. | 3779 |
15 |
| Other owners | 1201 |